Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > GLP-1 Effect After Sufonylurea Therapy	Display all items Journal Articles Discussion Articles Comments Discussions Conferences/Workshops Availabilities Grants/Funds Information/News

(Journal Article): Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
 
Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W
 
IN: Diabetes Care 1998; 21(11):1925-1931
Impact Factor(s) of Diabetes Care: 7.071 (2004), 7.501 (2003), 5.477 (2002), 5.404 (2001)

ABSTRACT: OBJECTIVE: Glucagon-like peptide 1 (GLP-1) has glucose-dependent insulinotropic and glucagonostatic actions in type 2 diabetic patients on diet and on oral agents. It is not known,... Click HERE for details